{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:13:07Z","timestamp":1785928387088,"version":"3.56.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy with notable genetic, epigenetic, and clinical heterogeneity. In this study, we used coding and noncoding sequencing (n = 74), including whole-genome sequencing (WGS) of 24 paired tumor-normal samples, targeted sequencing (n = 55), and DNA methylation in 126 patients to characterize the disease. From WGS, we identified recurrent, predominantly clonal coding mutations in KLF2 (50%), KMT2D (25%), and NOTCH2 (25%), alongside rare mutations in FLNC (8%), novel mutations in FAM135B (17%), and noncoding mutational hot spots in BCL6, PAX5, and BACH2 linked to aberrant somatic hypermutation. At least 1 noncoding hot spot was detected in 69% of patients. Copy number aberrations were present in 73% of patients, including del(7q) (27%), gain(3q) (17%), and trisomy 12 (13%). DNA methylation profiling revealed 2 epigenetic subgroups: high-risk (HR) SMZL (n = 67) and low-risk SMZL (n = 59). SMZL-HR was associated with adverse features, including female sex, IGHV1-2\u221704 usage, KLF2 mutations, del(7q), shorter telomeres, and elevated epigenetically determined cumulative mitoses scores. Transcriptomic analysis highlighted enhanced cell proliferation in SMZL-HR, with enrichment of E2F and G2M checkpoint pathways and epigenetic regulation via EZH2. Patients with SMZL-HR had significantly shorter time to first treatment (TTFT) (hazard ratio, 1.9; P = .003) and reduced overall survival (hazard ratio, 2.5; P = .039): 85% of patients with SMZL-HR required treatment and showed a higher frequency of transformation (P = .007) and mortality (P&amp;lt; .001). Multivariate analysis confirmed SMZL-HR as an independent predictor of shorter TTFT (hazard ratio, 2.4; P = .001). These findings demonstrate the role of DNA methylation and molecular profiling in SMZL risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019336","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:12:48Z","timestamp":1779883968000},"page":"4943-4957","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance"],"prefix":"10.1182","volume":"10","author":[{"given":"Helen","family":"Parker","sequence":"first","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3454-8723","authenticated-orcid":false,"given":"Amatta","family":"Mirandari","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4516-8945","authenticated-orcid":false,"given":"Benjamin","family":"Stevens","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9875-0998","authenticated-orcid":false,"given":"Carolina Jaramillo","family":"Oquendo","sequence":"additional","affiliation":[{"name":"2Genomic Informatics, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-5819","authenticated-orcid":false,"given":"Mart\u00ed","family":"Duran-Ferrer","sequence":"additional","affiliation":[{"name":"3Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7989-9404","authenticated-orcid":false,"given":"Lara","family":"Buermann","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4012-4577","authenticated-orcid":false,"given":"Harindra E.","family":"Amarasinghe","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"},{"name":"4Radcliffe Department of Investigative Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-9101","authenticated-orcid":false,"given":"Jaya","family":"Thomas","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Carr","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shama","family":"Syeda","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Methusha","family":"Sakthipakan","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Parry","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1064-5350","authenticated-orcid":false,"given":"Matthew J. J.","family":"Rose-Zerilli","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zadie","family":"Davis","sequence":"additional","affiliation":[{"name":"5Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"McIver-Brown","sequence":"additional","affiliation":[{"name":"5Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliki","family":"Xochelli","sequence":"additional","affiliation":[{"name":"6Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ennis","sequence":"additional","affiliation":[{"name":"2Genomic Informatics, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0844-0989","authenticated-orcid":false,"given":"Lydia","family":"Scarf\u00f2","sequence":"additional","affiliation":[{"name":"7Unit of B Cell Neoplasia and Strategic Research Program on Chronic Lymphocytic Leukaemia, Comprehensive Cancer Center, Instituto di Recovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-7342","authenticated-orcid":false,"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[{"name":"7Unit of B Cell Neoplasia and Strategic Research Program on Chronic Lymphocytic Leukaemia, Comprehensive Cancer Center, Instituto di Recovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy"},{"name":"8Medical School, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kalpadakis","sequence":"additional","affiliation":[{"name":"9University Hospital, University of Crete, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos","family":"Pangalis","sequence":"additional","affiliation":[{"name":"10Department of Haematology, Athens Medical Center, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rossi","sequence":"additional","affiliation":[{"name":"11Institute of Oncology, Universit\u00e0 della Svizzera Italiana, Bellinzona, Switzerland"},{"name":"12Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-0151","authenticated-orcid":false,"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[{"name":"12Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-0370","authenticated-orcid":false,"given":"Simon","family":"Wagner","sequence":"additional","affiliation":[{"name":"13Leicester Cancer Research Centre, Leicester Royal Infirmary, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2037-3926","authenticated-orcid":false,"given":"Matthew","family":"Ahearne","sequence":"additional","affiliation":[{"name":"13Leicester Cancer Research Centre, Leicester Royal Infirmary, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-369X","authenticated-orcid":false,"given":"Marc","family":"Seifert","sequence":"additional","affiliation":[{"name":"14Institut fur zellbiologie, Universitatsklinikum Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Plass","sequence":"additional","affiliation":[{"name":"15Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Weichenhan","sequence":"additional","affiliation":[{"name":"15Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-6131","authenticated-orcid":false,"given":"Eva","family":"Kimby","sequence":"additional","affiliation":[{"name":"16Unit of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley-Ann","family":"Sutton","sequence":"additional","affiliation":[{"name":"17Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0211-8788","authenticated-orcid":false,"given":"Richard","family":"Rosenquist","sequence":"additional","affiliation":[{"name":"17Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"18Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0901-5252","authenticated-orcid":false,"given":"Rose-Marie","family":"Amini","sequence":"additional","affiliation":[{"name":"19Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Ljungstr\u00f6m","sequence":"additional","affiliation":[{"name":"20Department of Biomedical Informatics, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-2852","authenticated-orcid":false,"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[{"name":"21School of Cancer Studies, University of Birmingham, Birmingham, United Kingdom"},{"name":"22Department of Haematology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-1831","authenticated-orcid":false,"given":"Francesco","family":"Forconi","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[{"name":"6Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-5977","authenticated-orcid":false,"given":"Marta","family":"Salido","sequence":"additional","affiliation":[{"name":"23Laboratori de Citologia Hematol\u00f2gica i Citogen\u00e8tica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3381-9472","authenticated-orcid":false,"given":"Ana","family":"Ferrer","sequence":"additional","affiliation":[{"name":"23Laboratori de Citologia Hematol\u00f2gica i Citogen\u00e8tica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[{"name":"24Service d'h\u00e9mato-oncologie, H\u00f4pital Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Assistante Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-6586","authenticated-orcid":false,"given":"Laura","family":"Hilton","sequence":"additional","affiliation":[{"name":"25Department of Molecular Biology and Biochemistry, Simon Fraser Univesity, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-7800","authenticated-orcid":false,"given":"Ryan","family":"Morin","sequence":"additional","affiliation":[{"name":"25Department of Molecular Biology and Biochemistry, Simon Fraser Univesity, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5693-2789","authenticated-orcid":false,"given":"Renata","family":"Walewska","sequence":"additional","affiliation":[{"name":"5Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5195","authenticated-orcid":false,"given":"Jos\u00e9 Ignacio","family":"Mart\u00edn-Subero","sequence":"additional","affiliation":[{"name":"3Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"26Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oscier","sequence":"additional","affiliation":[{"name":"5Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-9694","authenticated-orcid":false,"given":"Christopher","family":"Oakes","sequence":"additional","affiliation":[{"name":"27Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Gibson","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"},{"name":"28Bioinformatics Research Facility, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-608X","authenticated-orcid":false,"given":"Dean","family":"Bryant","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-2881","authenticated-orcid":false,"given":"Jonathan C.","family":"Strefford","sequence":"additional","affiliation":[{"name":"1Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"},{"name":"28Bioinformatics Research Facility, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"3","key":"2026072809363956800_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"2026072809363956800_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"issue":"7","key":"2026072809363956800_bib3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2026072809363956800_bib4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2026072809363956800_bib5","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3109\/10428194.2013.845884","article-title":"Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?","volume":"55","author":"Kalpadakis","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"17","key":"2026072809363956800_bib6","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management","volume":"127","author":"Arcaini","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2026072809363956800_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3109\/10428194.2013.818143","article-title":"Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use","volume":"55","author":"Montalban","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2026072809363956800_bib8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bjh.18912","article-title":"Low-risk HPLLs\/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: results from a prospective Spanish study","volume":"202","author":"Munta\u00f1ola","year":"2023","journal-title":"Br J Haematol"},{"issue":"12","key":"2026072809363956800_bib9","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2014-08-596247","article-title":"DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features","volume":"125","author":"Arribas","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2026072809363956800_bib10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.2021012386","article-title":"Genetic and phenotypic attributes of splenic marginal zone lymphoma","volume":"139","author":"Bonfiglio","year":"2022","journal-title":"Blood"},{"issue":"11","key":"2026072809363956800_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s43018-020-00131-2","article-title":"The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome","volume":"1","author":"Duran-Ferrer","year":"2020","journal-title":"Nat Cancer"},{"issue":"7924","key":"2026072809363956800_bib12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-022-05072-7","article-title":"Diverse mutational landscapes in human lymphocytes","volume":"608","author":"Machado","year":"2022","journal-title":"Nature"},{"issue":"18","key":"2026072809363956800_bib13","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2026072809363956800_bib14","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2026072809363956800_bib15","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/leu.2015.217","article-title":"Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial","volume":"29","author":"Strefford","year":"2015","journal-title":"Leukemia"},{"issue":"43","key":"2026072809363956800_bib16","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026072809363956800_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.immuni.2015.12.006","article-title":"Compendium of immune signatures identifies conserved and species-specific biology in response to inflammation","volume":"44","author":"Godec","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"2026072809363956800_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"issue":"6","key":"2026072809363956800_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"7","key":"2026072809363956800_bib20","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/s41375-023-01918-9","article-title":"Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL","volume":"37","author":"Bryant","year":"2023","journal-title":"Leukemia"},{"issue":"16","key":"2026072809363956800_bib21","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/bloodadvances.2019000237","article-title":"Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials","volume":"3","author":"Wojdacz","year":"2019","journal-title":"Blood Adv"},{"key":"2026072809363956800_bib22","unstructured":"Hovestadt\n              V\n            , ZapatkaM. Enhanced copy-number variation analysis using illumina DNA methylation arrays. http:\/\/bioconductor.org\/packages\/conumee\/."},{"key":"2026072809363956800_bib23","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat Commun"},{"issue":"7","key":"2026072809363956800_bib24","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2026072809363956800_bib25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41588-022-01211-y","article-title":"Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features","volume":"54","author":"Robbe","year":"2022","journal-title":"Nat Genet"},{"issue":"2","key":"2026072809363956800_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/bioinformatics\/btaa672","article-title":"A statistical approach for tracking clonal dynamics in cancer using longitudinal next-generation sequencing data","volume":"37","author":"Vavoulis","year":"2021","journal-title":"Bioinformatics"},{"issue":"12","key":"2026072809363956800_bib27","doi-asserted-by":"crossref","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma","volume":"8","author":"Parry","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"2026072809363956800_bib28","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1038\/s41598-019-46906-1","article-title":"Systematic review of somatic mutations in splenic marginal zone lymphoma","volume":"9","author":"Jaramillo Oquendo","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"2026072809363956800_bib29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"2026072809363956800_bib30","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"2026072809363956800_bib63","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2026072809363956800_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/path.2665","article-title":"Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis","volume":"220","author":"Watkins","year":"2010","journal-title":"J Pathol"},{"issue":"9","key":"2026072809363956800_bib33","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"issue":"45","key":"2026072809363956800_bib34","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7354","key":"2026072809363956800_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"24","key":"2026072809363956800_bib36","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"issue":"7360","key":"2026072809363956800_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"7339","key":"2026072809363956800_bib38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"issue":"2","key":"2026072809363956800_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet"},{"issue":"21","key":"2026072809363956800_bib40","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/1078-0432.CCR-16-0609","article-title":"Recurrent mutations in the MTOR regulator RRAGC in follicular lymphoma","volume":"22","author":"Ying","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2026072809363956800_bib41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s42255-019-0098-8","article-title":"Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR","volume":"1","author":"Ortega-Molina","year":"2019","journal-title":"Nat Metab"},{"issue":"2","key":"2026072809363956800_bib42","doi-asserted-by":"crossref","first-page":"109372","DOI":"10.1016\/j.celrep.2021.109372","article-title":"Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs","volume":"36","author":"Ortega-Molina","year":"2021","journal-title":"Cell Rep"},{"key":"2026072809363956800_bib43","doi-asserted-by":"crossref","first-page":"1176698","DOI":"10.3389\/fonc.2023.1176698","article-title":"Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study","volume":"13","author":"Haider","year":"2023","journal-title":"Front Oncol"},{"issue":"11","key":"2026072809363956800_bib31","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/1055-9965.EPI-06-0436","article-title":"Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers","volume":"15","author":"Nakajima","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2026072809363956800_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1442-2050.2008.00862.x","article-title":"Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus","volume":"22","author":"Kim","year":"2009","journal-title":"Dis Esophagus"},{"issue":"4","key":"2026072809363956800_bib44","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.18632\/oncotarget.14087","article-title":"Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma","volume":"8","author":"Tanabe","year":"2017","journal-title":"Oncotarget"},{"issue":"42","key":"2026072809363956800_bib45","doi-asserted-by":"crossref","first-page":"68242","DOI":"10.18632\/oncotarget.11921","article-title":"Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma","volume":"7","author":"Qi","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"2026072809363956800_bib46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/07357900802620794","article-title":"Hypermethylation of genes for diagnosis and risk stratification of prostate cancer","volume":"27","author":"Vanaja","year":"2009","journal-title":"Cancer Invest"},{"issue":"47","key":"2026072809363956800_bib47","doi-asserted-by":"crossref","first-page":"82430","DOI":"10.18632\/oncotarget.19397","article-title":"Vinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migration","volume":"8","author":"Ai","year":"2017","journal-title":"Oncotarget"},{"issue":"D1","key":"2026072809363956800_bib48","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2026072809363956800_bib49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41571-019-0190-8","article-title":"Emerging epigenetic-modulating therapies in lymphoma","volume":"16","author":"Sermer","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"18","key":"2026072809363956800_bib50","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","article-title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","volume":"122","author":"B\u00f6d\u00f6r","year":"2013","journal-title":"Blood"},{"issue":"7574","key":"2026072809363956800_bib51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"1-2","key":"2026072809363956800_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428199809057583","article-title":"BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications","volume":"31","author":"Gaidano","year":"1998","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2026072809363956800_bib53","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood.V84.11.3850.bloodjournal84113850","article-title":"Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2\/lyt-10 gene in lymphoid malignancies","volume":"84","author":"Migliazza","year":"1994","journal-title":"Blood"},{"issue":"suppl 1","key":"2026072809363956800_bib54","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2024-208175","article-title":"Non-coding mutations of BCL6 in classical Hodgkin lymphoma","volume":"144","author":"Pirosa","year":"2024","journal-title":"Blood"},{"issue":"12","key":"2026072809363956800_bib55","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41588-023-01561-1","article-title":"Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression","volume":"55","author":"Leeman-Neill","year":"2023","journal-title":"Nat Genet"},{"issue":"6844","key":"2026072809363956800_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"issue":"10","key":"2026072809363956800_bib57","first-page":"1405","article-title":"Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma","volume":"91","author":"Rossi","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"2026072809363956800_bib58","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2005-10-3949","article-title":"Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma","volume":"108","author":"Liso","year":"2006","journal-title":"Blood"},{"issue":"11","key":"2026072809363956800_bib59","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.18632\/oncotarget.653","article-title":"Recurrent targets of aberrant somatic hypermutation in lymphoma","volume":"3","author":"Khodabakhshi","year":"2012","journal-title":"Oncotarget"},{"issue":"3","key":"2026072809363956800_bib60","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.159.3.1068","article-title":"Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro","volume":"159","author":"Hu","year":"1997","journal-title":"J Immunol"},{"issue":"7","key":"2026072809363956800_bib61","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/modpathol.2012.220","article-title":"Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling","volume":"26","author":"Arribas","year":"2013","journal-title":"Mod Pathol"},{"issue":"5","key":"2026072809363956800_bib62","doi-asserted-by":"crossref","first-page":"e70147","DOI":"10.1002\/hem3.70147","article-title":"Antigen selection reflected in the subclonal architecture of the B-cell receptor immunoglobulin gene repertoire in splenic marginal zone lymphoma","volume":"9","author":"Zaragoza-Infante","year":"2025","journal-title":"Hemasphere"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/14\/4943\/2533573\/blooda_adv-2025-019336-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/14\/4943\/2533573\/blooda_adv-2025-019336-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:36:53Z","timestamp":1785245813000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/14\/4943\/568745\/Integrated-multiomic-profiling-reveals-2-distinct"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":64,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019336","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,28]]},"published":{"date-parts":[[2026,7,16]]}}}